UBS Group’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.02M Buy
3,867,213
+2,241,916
+138% +$1.89M ﹤0.01% 4587
2025
Q4
$1.27M Sell
1,625,297
-2,880,658
-64% -$2.36M ﹤0.01% 5377
2025
Q3
$3.25M Buy
4,505,955
+2,760,238
+158% +$12.5M ﹤0.01% 4479
2025
Q2
$8.85M Buy
1,745,717
+108,531
+7% +$427K ﹤0.01% 3202
2025
Q1
$4.94M Buy
1,637,186
+1,407,610
+613% +$5.13M ﹤0.01% 3786
2024
Q4
$831K Buy
+229,576
New +$695K ﹤0.01% 5454
2024
Q2
Sell
-20,192
Closed -$39.4K 10234
2024
Q1
$39.4K Buy
20,192
+3,766
+23% +$6.57K ﹤0.01% 6619
2023
Q4
$23.2K Buy
16,426
+12,027
+273% +$15.4K ﹤0.01% 7014
2023
Q3
$6.95K Buy
+4,399
New +$8.14K ﹤0.01% 7259
2023
Q2
Sell
-1,000
Closed -$2.1K 9786
2023
Q1
$2.1K Buy
+1,000
New +$2.19K ﹤0.01% 8582
2022
Q4
Sell
-5,975
Closed -$18K 11227
2022
Q3
$18K Buy
5,975
+3,975
+199% +$13.3K ﹤0.01% 7546
2022
Q2
$6K Sell
2,000
-2,000
-50% -$7.23K ﹤0.01% 8740
2022
Q1
$21K Buy
4,000
+2,868
+253% +$16.3K ﹤0.01% 7411
2021
Q4
$8K Buy
+1,132
New +$9.45K ﹤0.01% 9069
2021
Q3
Sell
-3,164
Closed -$15K 10176
2021
Q2
$15K Buy
+3,164
New +$13.5K ﹤0.01% 7655
2020
Q4
Sell
-1,637
Closed -$5K 8838
2020
Q3
$5K Sell
1,637
-38,412
-96% -$158K ﹤0.01% 7344
2020
Q2
$178K Buy
40,049
+2,050
+5% +$7.44K ﹤0.01% 4887
2020
Q1
$106K Buy
37,999
+34,551
+1,002% +$149K ﹤0.01% 5249
2019
Q4
$14K Buy
+3,448
New +$13.3K ﹤0.01% 7107
2019
Q3
Sell
-1,931
Closed -$10K 8312
2019
Q2
$10K Buy
+1,931
New +$13.1K ﹤0.01% 7085
2019
Q1
Hold
0
8249
2018
Q4
Hold
0
8358
2018
Q3
Hold
0
8323
2018
Q2
Hold
0
8312
2018
Q1
Sell
-261
Closed -$12.2K 8224
2017
Q4
$13K Sell
261
-191
-42% -$11.7K ﹤0.01% 6876
2017
Q3
$32K Buy
+452
New +$20.9K ﹤0.01% 6120
2017
Q2
Sell
-7
Closed 8040
2017
Q1
$0 Sell
7
-106
-94% -$4.85K ﹤0.01% 8041
2016
Q4
$3K Sell
113
-1,347
-92% -$55.3K ﹤0.01% 7439
2016
Q3
$65K Sell
1,460
-423
-22% -$18.3K ﹤0.01% 5302
2016
Q2
$74K Buy
1,883
+509
+37% +$23.7K ﹤0.01% 5238
2016
Q1
$76K Sell
1,374
-200
-13% -$15.2K ﹤0.01% 5177
2015
Q4
$216K Buy
1,574
+438
+39% +$62.3K ﹤0.01% 4607
2015
Q3
$163K Buy
1,136
+368
+48% +$83.9K ﹤0.01% 4803
2015
Q2
$199K Buy
+768
New +$238K ﹤0.01% 4877

Other funds holding ATYR